Chloe Botaine

Chloe Botaine

Biopharmaceutical Research Specialist
Chloe Botaine specializes in biopharmaceutical research and development, offering insights into the latest trends, challenges, and breakthroughs in biopharma. Her content covers topics such as drug discovery, clinical trials, and regulatory affairs. With a focus on advancing science and improving patient care, Chloe’s content contributes to the development of innovative therapies and medicines that address unmet medical needs and improve public health outcomes.
AI Powered Narrow Spectrum Antibiotics – Review
Tech & Innovation AI Powered Narrow Spectrum Antibiotics – Review

For a disease that quietly affects nearly half a million Americans each year, a precision antibiotic that erases Borrelia burgdorferi while leaving the microbiome intact would shift Lyme treatment from blunt-force regimens to targeted, durable care that preserves health far beyond the infection

EU Approves Enflonsia for Season-Long Infant RSV Prevention
Management & Regulatory EU Approves Enflonsia for Season-Long Infant RSV Prevention

Chloe Botaine sat down with Ivan Kairatov, a Biopharma expert with deep R&D and tech experience, to discuss the European Commission’s approval of a long-acting monoclonal antibody for RSV prevention in newborns and infants. With a single intramuscular dose designed to protect for up to five months,

Can Generative AI Design Soluble, Synthesizable Antibiotics?
Tech & Innovation Can Generative AI Design Soluble, Synthesizable Antibiotics?

Hospitals feel the squeeze as drug-resistant infections outpace discovery, while conventional screening drains time and money without delivering medicines that dissolve, distribute, and survive the real world. That pressure has pushed researchers to reimagine how drugs are created, trading

AI Uses EHRs to Predict ADHD Risk Years Before Diagnosis
Tech & Innovation AI Uses EHRs to Predict ADHD Risk Years Before Diagnosis

A pediatrician opens a child’s electronic chart and scans years of well-visit notes, immunization stamps, brief school concerns, and sleep complaints, and in the space between those ordinary lines an algorithm quietly surfaces a pattern that suggests the child’s risk for

Are Mobile-First Apps the New Engine of GLP-1 Care?
Tech & Innovation Are Mobile-First Apps the New Engine of GLP-1 Care?

Admission to GLP-1 therapy once crawled through a maze of clinic calendars, phone tag, and insurer scripts, but a wave of purpose-built telehealth apps has turned that maze into a guided lane on a phone that now functions as both navigator and engine. The change was not merely cosmetic. Adaptive

Can Engineered BEVs Be the Next Weapon Against AMR?
Research & Development Can Engineered BEVs Be the Next Weapon Against AMR?

Relentless rises in drug-resistant infections have turned routine care into a negotiation with risk that standard antibiotics too often lose, and the search for smarter countermeasures has shifted to tools built by biology itself. Bacterial extracellular vesicles (BEVs) sit at that inflection

How Can Mobile Devices Secure Sensitive Healthcare Data?
Tech & Innovation How Can Mobile Devices Secure Sensitive Healthcare Data?

Healthcare facilities across the United States are currently navigating an era of unprecedented digital transformation where the rapid retrieval of patient data is essential for emergency clinical decision-making. However, the convenience of using mobile tablets and smartphones at the bedside

Tumor Cell Mapping Predicts Melanoma Treatment Success
Management & Regulatory Tumor Cell Mapping Predicts Melanoma Treatment Success

The recent breakthrough in oncological research has shifted the paradigm from analyzing what a tumor is composed of to understanding exactly how its internal components are physically positioned. Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified that the spatial

Atomic Map of Vibrio Bacteria Helps Disarm Deadly Infections
Research & Development Atomic Map of Vibrio Bacteria Helps Disarm Deadly Infections

The warming of coastal waters along the Atlantic and Mediterranean has accelerated the proliferation of Vibrio bacteria, creating an urgent public health crisis that demands immediate scientific intervention. As these pathogens thrive in rising temperatures, traditional medical approaches find

Can Moderna’s Bird Flu Vaccine Survive Without US Funding?
Management & Regulatory Can Moderna’s Bird Flu Vaccine Survive Without US Funding?

The abrupt cessation of nearly eight hundred million dollars in federal support has forced a paradigm shift in how the pharmaceutical industry approaches pandemic preparedness and biotechnological research. The landscape of global health security is currently witnessing a high-stakes test of

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later